| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-702-90 | 62135-702 | HUMAN PRESCRIPTION DRUG | Amoxapine | Amoxapine | TABLET | ORAL | 20230906 | N/A | ANDA | ANDA072879 | Chartwell RX, LLC | AMOXAPINE | 100 mg/1 | 90 TABLET in 1 BOTTLE (62135-702-90) |
| 62135-703-30 | 62135-703 | HUMAN PRESCRIPTION DRUG | Amoxapine | Amoxapine | TABLET | ORAL | 20230906 | N/A | ANDA | ANDA072879 | Chartwell RX, LLC | AMOXAPINE | 150 mg/1 | 30 TABLET in 1 BOTTLE (62135-703-30) |
| 62135-701-90 | 62135-701 | HUMAN PRESCRIPTION DRUG | Amoxapine | Amoxapine | TABLET | ORAL | 20230906 | N/A | ANDA | ANDA072879 | Chartwell RX, LLC | AMOXAPINE | 50 mg/1 | 90 TABLET in 1 BOTTLE (62135-701-90) |
| 62135-700-90 | 62135-700 | HUMAN PRESCRIPTION DRUG | Amoxapine | Amoxapine | TABLET | ORAL | 20230906 | N/A | ANDA | ANDA072879 | Chartwell RX, LLC | AMOXAPINE | 25 mg/1 | 90 TABLET in 1 BOTTLE (62135-700-90) |